Drug Profile
Research programme: heparanase inhibitors - UCB
Alternative Names: Heparanase inhibitors research programme - Celltech Group; OGT 2492Latest Information Update: 13 Jan 2009
Price :
$50
*
At a glance
- Originator UCB
- Class Small molecules
- Mechanism of Action Heparanase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer